• Product nameAnti-CD36 antibody [VM58]
    See all CD36 primary antibodies
  • Description
    Mouse monoclonal [VM58] to CD36
  • SpecificityThe monoclonal antibody VM58 is directed against the CD36 antigen, a 90kD glycoprotein, also called GP IIIb expressed on human platelets. The GP IV (GP IIIb) molecule has been shown to function as thrombospondin receptor on platelets and monocytes and as receptor for Plasmodium falciparum infected erythrocytes. The monoclonal antibody reacts with platelets, monocytes, macrophages, erythroblasts and (weakly) with B-cells. In immunohistology the monoclonal antibody reacts with some endothelial cells, adipocytes and the granular layer of the skin. The antibody VM58 induces Fc-receptor-dependent platelet aggregation after binding to platelet. The heterogeneity of the response found in healthy individuals is dependent on the polymorphism of the Fc RII on platelets.
  • Tested applicationsIHC-Fr, ICC/IFmore details
  • Species reactivity
    Reacts with: Human
  • Immunogen

    Human monocytes.



Our Abpromise guarantee covers the use of ab8145 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
  • Application notesIF: Use at an assay dependent concentration. Fixation with 1% paraformaldehyde for 5 min. is advised.
    IHC-Fr: Use at an assay dependent dilution.

    Is unsuitable for WB.

    Not yet tested in other applications.
    Optimal dilutions/concentrations should be determined by the end user.
  • Target

    • FunctionSeems to have numerous potential physiological functions. Binds to collagen, thrombospondin, anionic phospholipids and oxidized LDL. May function as a cell adhesion molecule. Directly mediates cytoadherence of Plasmodium falciparum parasitized erythrocytes. Binds long chain fatty acids and may function in the transport and/or as a regulator of fatty acid transport. Receptor for thombospondins, THBS1 AND THBS2, mediating their antiangiogenic efects.
    • Involvement in diseaseDefects in CD36 are the cause of platelet glycoprotein IV deficiency (PG4D)[MIM:608404]; also known as CD36 deficiency. Platelet glycoprotein IV deficiency can be divided into 2 subgroups. The type I phenotype is characterized by platelets and monocytes/macrophages exhibiting complete CD36 deficiency. The type II phenotype lacks the surface expression of CD36 in platelets, but expression in monocytes/macrophages is near normal.
      Genetic variations in CD36 are associated with susceptibility to coronary heart disease type 7 (CHDS7) [MIM:610938].
    • Sequence similaritiesBelongs to the CD36 family.
    • Post-translational
      N-glycosylated and O-glycosylated with a ratio of 2:1.
    • Cellular localizationMembrane.
    • Information by UniProt
    • Database links
    • Alternative names
      • Adipocyte membrane protein antibody
      • CD36 antibody
      • CD36 antigen (collagen type I receptor, thrombospondin receptor) antibody
      • CD36 antigen antibody
      • CD36 molecule (thrombospondin receptor) antibody
      • CD36 molecule antibody
      • CD36_HUMAN antibody
      • CHDS7 antibody
      • Cluster determinant 36 antibody
      • Collagen receptor, platelet antibody
      • FAT antibody
      • Fatty acid translocase antibody
      • Fatty acid transport protein antibody
      • Glycoprotein IIIb antibody
      • GP IIIb antibody
      • GP3B antibody
      • GP4 antibody
      • GPIIIB antibody
      • GPIV antibody
      • Leukocyte differentiation antigen CD36 antibody
      • MGC108510 antibody
      • MGC91634 antibody
      • PAS 4 protein antibody
      • PAS IV antibody
      • PAS-4 antibody
      • PASIV antibody
      • Platelet collagen receptor antibody
      • Platelet glycoprotein 4 antibody
      • Platelet glycoprotein IV antibody
      • scarb3 antibody
      • Scavenger receptor class B member 3 antibody
      • Thrombospondin receptor antibody
      see all

    References for Anti-CD36 antibody [VM58] (ab8145)

    This product has been referenced in:
    • Vinogradov DV  et al. [Inhibition of Fc-receptor dependent platelet aggregation by monoclonal antibodies against the glycoprotein IIb-IIIa complex] Biokhimiia 56:787-97 (1991). Read more (PubMed: 1747408) »

    See 1 Publication for this product

    Product Wall

    Thank you for your enquiry. I am sorry you are experiencing problems with this antibody. Below please find the link to a questionnaire that may help me in addition to what we discussed over the phone. Once you have submitted the form to us, we wil...

    Read More

    Thank you for your email. Ab8145 does cross-react with human and has been tested for application in IHC-frozen sections. You can read feedback from customers regarding this antibody by clicking on the reviews and enquiries tabs located on the online da...

    Read More

    Thank you for your enquiry. This antibody has not yet been tested for use with paraffin embedded tissue. Should you decide to go ahead and test this antibody, please let us know how you get on, and in return we will forward a USD15/EUR15/GBP10 Amazon g...

    Read More

    We curently do not stock, or are aware of any other company which produces, a commercially available control for this antibody. Since this antibody cross reacts with inflammatory cells and b-cells, maybe a section of lymphoid tissue such as spleen or t...

    Read More

    The antibody ab8145 to CD36 will work well with live cells. However, precautions should be taken to avoid aggregation of platelets that might be caused by this antibody.

    This antibody was raised in mouse and therefore it is unlikely that this antibody will cross-react with mouse or rat CD36